Weekly | Can ASX Hold Gains as $WTC $PME $XRO $PLS $TNE Rise 11%+ Lead the Rally?

Australian shares snapped a three-week winning streak as investors trimmed positions before the weekend, with caution returning across Asia despite tentative progress on extending the US-Iran ceasefire.

The $S&P/ASX 200(XJO.AU)$ fell 8.1 points, or 0.1%, to 8946.9, with six of the 11 sectors in the red. But the benchmark up 0.39% for the week after posting its strongest rise in four years on hopes tensions in the Middle East would ease.

Here are the key reasons for the strong week performance (up to April 17, 2026 close) of these ASX stocks, based on the most recent market developments, sector sentiment shifts, and company-specific updates.

1. $WISETECH GLOBAL LTD(WTC.AU)$ +22.72%

WiseTech shares surged amid a broader ASX tech sector recovery, with the S&P/ASX 200 Information Technology Index rising sharply as macro fears (e.g., geopolitical tensions and inflation) eased.

• Sector-wide tech rebound and sentiment recovery: Shares rose ~26% in the week as investors rotated back into ASX tech names, with WTC leading gains on reduced macro concerns following a US tech rally and easing fears around global disruptions.

• AI transformation acceleration and cost efficiencies: The company is advancing AI integration to strengthen its CargoWise platform moat, with phased headcount reductions (up to 50% in product/development and customer service areas) expected to deliver major internal efficiencies and support margin recovery.

• E2open acquisition progress and synergies: The debt-funded US cloud logistics acquisition is on track for H1 2026 close, already contributing to strong revenue growth; early cost synergies of $50m annualized run-rate were achieved ahead of schedule, with the deal viewed as earnings-accretive in year one.

• Reaffirmed FY26 guidance with strong H1 momentum: 1H26 revenue reached US$672m (+76% YoY, +7% organic), CargoWise revenue +12%, and organic EBITDA margin held at 51%. FY26 guidance reaffirmed at revenue US$1.39–1.44b (+79–85% growth) and EBITDA US$550–585m.

2. $PRO MEDICUS LTD(PME.AU)$ +17.19%

PME rebounded strongly on a string of high-value US contract wins/renewals in radiology imaging software, signaling resilient demand and pricing power despite earlier AI-related valuation pressures.

• Multiple major US contract wins and renewals: In April 2026 alone, announcements included a A$37m 5-year renewal with Northwestern Medicine (Visage 7 platform, transaction-based) and other deals (e.g., University of Maryland A$23m), contributing to over A$100m in combined minimum contract value in recent weeks.

• Strong H1 FY2026 financial performance: Revenue +28.4% to A$124.8m; underlying PBT +29.7% to A$90.7m, with high margins (underlying EBIT ~73%) and robust cash position (~A$222m) highlighting operational strength.

• Pricing power and customer retention: Renewals often at higher transaction fees, demonstrating stickiness in the large US market and countering earlier AI competition fears; volume-based structures provide upside beyond minimums.

• Broader healthcare tech resilience amid sector rotation: Gains reflected renewed investor confidence in specialized imaging software, with shares up significantly over short periods on positive contract momentum despite earlier 2026 volatility.

Latest financial/technical data: High valuation persists (P/S historically elevated, recently ~90x vs. 5-year avg ~83x); strong ROE (~73% in recent periods); shares showed momentum with gains of ~19–22% in recent 5-day windows. Cash-rich balance sheet supports ongoing expansion.

3. $XERO LTD(XRO.AU)$ +14.72%

Xero participated in the ASX tech rally as a high-quality growth name trading at a reset valuation after earlier sell-offs driven by AI disruption fears and macro pressures.

• Attractive valuation reset attracting bargain hunters: Shares had fallen ~35% YTD (and more from peaks) due to sector rotation, creating an entry point; analysts largely maintain Buy/Strong Buy ratings with targets implying substantial upside (up to ~92–215% in some forecasts).

• Solid core subscription growth and platform scalability: Ongoing mid-to-high teens growth in subscribers and ARPU across Australia, NZ, and UK; proactive AI strategy embedded in the cloud accounting platform to enhance offerings without major disruption risks.

• Margin improvement and cost discipline: Recent periods showed operating margin expansion (>500bps in H1 FY26 examples) as subscription revenue outpaced spending; scalable model supports long-term profitability.

• Broader tech sector sentiment shift: Recovery alongside peers like WTC and TNE as investors reassessed AI fears as overdone, with Xero's sticky small-business customer base viewed as resilient.

4. $PLS Group Ltd(PLS.AU)$ +12.69%

PLS hit all-time highs on lithium price recovery and a successful debt raise, reinforcing confidence in its production and expansion plans.

• Successful upsized US$600m senior notes offering: Priced above the initial US$500m target (due 2031) for debt refinancing and general corporate purposes, providing capital structure flexibility at a time of record share prices and improving lithium sentiment.

• Rising lithium prices and production momentum: Lithium carbonate prices in China continued climbing into April 2026; realized prices and volumes supported strong prior-period EBITDA/NPAT growth (e.g., +241% EBITDA in recent reported half on +40% realized price).

• Operational leverage to commodity recovery: As a low-cost producer, higher prices flow directly to profits; recent production increases and potential restarts (e.g., Ngungaju considerations) add upside amid recovering market conditions.

• Institutional and sentiment support: Strong buying interest as lithium sector sentiment turned positive, with shares up dramatically over 6–12 months on the rebound.

5. $TECHNOLOGY ONE LTD(TNE.AU)$ +11.34%

TNE benefited from the tech rebound and confidence in its SaaS+ strategy, supported by an earlier guidance upgrade tied to AI enhancements.

• AI-driven confidence and SaaS+ momentum: CEO highlighted AI as a "not so secret weapon" turbocharging products; this underpinned the February FY26 guidance upgrade (PBT growth 18–20% from 13–17%; ARR 16–18%), boosting visibility into customer pipelines in Australia, NZ, and UK.

• Sticky enterprise software model with recurring revenue: Mission-critical ERP solutions for governments, universities, and enterprises provide high retention and switching costs; focus on public sector and multi-year contracts supports steady growth.

• Guidance delivery and margin outlook: Upgrades reflected strong execution; historical revenue growth (~18% in FY25 to A$598.5m) and EPS growth continue, with expectations of sustained double-digit expansion.